All In Biotech

Drug Trial Radar · NCT04711915

Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans

Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

10

Planned (sponsor's estimate)

Start

Mar 17, 2021

Primary completion

Jul 1, 2030

Study completion Dec 1, 2030

Sponsor

Lead sponsor
Yale UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 15, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Crossover
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 21 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this fixed order, open-label, dose-escalation study is to investigate the safety and efficacy of specific doses of dimethyltryptamine (DMT) in humans.

Conditions

  • Major Depressive Disorder
  • Depression

Interventions

  • 0.1 mg/kg Dimethyltryptamine (DMT)Drug

    0.1 mg/kg DMT

  • 0.3 mg/kg Dimethyltryptamine (DMT)Drug

    0.3 mg/kg DMT

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Blood PressureTime frame: -60 and -30 minutes before DMT administration; 0, +5, +10, +15, +20, +30, +45, +60, and +120 minutes after DMT administration
  2. Change in Heart RateTime frame: -60 and -30 minutes before DMT administration; 0, +5, +10, +15, +20, +30, +45, +60, and +120 minutes after DMT administration
  3. Change in Psychedelic EffectsTime frame: -60 minutes before DMT administration; 0, +30, and +60 minutes after DMT administration
  4. Change in AnxietyTime frame: -60 minutes before DMT administration; 0, +30, and +60 minutes after DMT administration
  5. Drug Reinforcing EffectsTime frame: +120 minutes after DMT administration
  6. Overall Tolerability assessed by the VASTime frame: +120 minutes after DMT administration

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine

    West Haven, Connecticut · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.